US Patent 7144873 Kit for delivering decitabine in vivo

Patent 7144873 was granted and assigned to SUPERGEN, INC. on December, 2006 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 11 Oct, 2023

"update inverses"

Golden AI

edited on 11 Oct, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11779591 Compositions containing decitabine, 5azacytidine and tetrahydrouridine and uses thereof

Edits on 6 Sep, 2023

"Add patent inventor(s)"

Golden AI

edited on 6 Sep, 2023

Edits made to:

Infobox (+5 properties)

Infobox

Patent Inventor Names

Ashok Y. Gore0

Rajashree Joshi-Hangal0

Sanjeev Redkar0

Stephanie Gong0

Xichen Zhang0

Edits on 31 Aug, 2023

"Add patent abstract"

Golden AI

edited on 31 Aug, 2023

Edits made to:

Article (+637 characters)

Article

Patent abstract

Pharmaceutical formulations, kits and vessels are provided for delivering decitabine to a patient suffering from a disease in need of treatment with decitabine. The pharmaceutical formulation comprises decitabine solvated in a non-aqueous solvent that comprises glycerin, propylene glycol, polyethylene glycol, or combinations. Such formulations are more chemically stable than conventional liquid formulations of decitabine containing more than 40% water in volume. The pharmaceutical formulations can be used for any disease that is sensitive to the treatment with decitabine, such as hematological disorders and cancer.

Edits on 22 Jul, 2023

"Remove website redirecting to Patent Public Search front page"

Golden AI

edited on 22 Jul, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=071448730

Edits on 25 May, 2023

"Remove leading 0 from patent number"

Golden AI